CUCCHIARA, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 806
EU - Europa 693
AS - Asia 212
AF - Africa 80
Totale 1.791
Nazione #
US - Stati Uniti d'America 802
IT - Italia 306
SE - Svezia 158
SG - Singapore 96
CN - Cina 53
CI - Costa d'Avorio 47
AT - Austria 42
BG - Bulgaria 38
DE - Germania 36
GB - Regno Unito 36
PL - Polonia 25
IN - India 13
NG - Nigeria 13
SN - Senegal 13
HK - Hong Kong 12
FR - Francia 10
TR - Turchia 9
FI - Finlandia 8
VN - Vietnam 8
BE - Belgio 7
ES - Italia 7
EG - Egitto 6
JO - Giordania 6
RO - Romania 6
CH - Svizzera 5
CA - Canada 4
IL - Israele 4
JP - Giappone 4
CZ - Repubblica Ceca 3
SA - Arabia Saudita 3
IE - Irlanda 2
KR - Corea 2
UA - Ucraina 2
ID - Indonesia 1
LK - Sri Lanka 1
NL - Olanda 1
PT - Portogallo 1
TG - Togo 1
Totale 1.791
Città #
Chandler 140
Milan 87
Fairfield 64
Abidjan 47
Ashburn 43
Boardman 43
Singapore 42
Vienna 42
Sofia 38
New York 35
Florence 33
Santa Clara 33
Wilmington 32
Houston 30
London 27
Seattle 27
Princeton 25
Lawrence 23
Woodbridge 23
Cambridge 22
Pisa 22
Warsaw 22
Turin 21
Medford 20
Chicago 19
San Diego 19
Serra 18
Frankfurt am Main 16
Ogden 14
Dakar 13
Lagos 13
Hong Kong 12
Rome 11
Ann Arbor 10
Istanbul 8
Quanzhou 8
Brussels 7
Falls Church 7
Amman 6
Bremen 6
Helsinki 6
Stockholm 6
Al Mansurah 5
Baia Mare 5
Beijing 5
Hyderabad 5
Los Angeles 5
Shanghai 5
Vicopisano 5
Bern 4
Fuzhou 4
Mazara del Vallo 4
Monza 4
Redwood City 4
Tel Aviv 4
Bromsgrove 3
Carrara 3
Dong Ket 3
Hangzhou 3
Marseille 3
Monteu Roero 3
Munich 3
Olomouc 3
Riyadh 3
Toronto 3
Washington 3
Wuhan 3
Anzio 2
Barcelona 2
Dearborn 2
Ernakulam 2
Fairburn 2
Fisciano 2
Guangzhou 2
Hanau 2
Livermore 2
Palermo 2
Philadelphia 2
Pune 2
San Cristóbal de La Laguna 2
Seregno 2
Torino 2
Vigo 2
Boston 1
Cairo 1
Casaleone 1
Chehalis 1
Chengdu 1
Coimbra 1
Corcelles-pres-Payerne 1
Council Bluffs 1
Des Moines 1
Dongguan 1
Esslingen am Neckar 1
Formigine 1
Fulham 1
Gdansk 1
Genoa 1
Jakarta 1
Jiaxing 1
Totale 1.284
Nome #
Procedimento attuato per mezzo di un elaboratore per la determinazione dei tempi di ritenzione e dei valori di concentrazione di analiti in una miscela 129
Electrophysiological features of sleep in children with Kir4.1 channel mutations and Autism-Epilepsy phenotype: a preliminary study 118
A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference LC-MS/MS 99
Pharmacological effects of the simultaneous and sequential combinations of trifluridine/tipiracil (TAS-102) and 5-fluorouracil in fluoropyrimidine-sensitive colon cancer cells 89
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 83
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 82
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide 78
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 77
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 75
Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours? 74
ErbB in NSCLC as a molecular target: Current evidences and future directions 73
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 70
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 64
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 64
Determination of mitotane and metabolite by a simple HPLC-UV method and application in plasma samples 61
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone 58
null 54
Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview 52
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 52
Understanding EGFR heterogeneity in lung cancer 50
Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population 49
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer 47
Historical Overview of the "Firing" Liaison between Brain Tumors and Epilepsy 44
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 35
Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC 33
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 32
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients 31
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival 31
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours 30
Updates on liquid biopsy: Current trends and future perspectives for clinical application in solid tumors 15
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma 13
Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: Preclinical and clinical data 5
Totale 1.867
Categoria #
all - tutte 8.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 0 0 9 18 9 12 8 8 6 6
2020/2021159 2 7 3 15 10 7 43 9 30 5 9 19
2021/2022267 1 1 1 1 29 95 16 8 12 21 23 59
2022/2023639 88 87 51 39 69 64 17 54 117 5 45 3
2023/2024510 42 72 65 33 50 64 27 20 5 28 39 65
2024/2025203 40 34 26 58 45 0 0 0 0 0 0 0
Totale 1.867